Net Cash Provided by (Used in) Financing Activities in USD of NAVIDEA BIOPHARMACEUTICALS, INC. from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was -$201K, a 40.9% increase year-over-year.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7.14M, a 41% decline from 2021.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $12.1M, a 18.6% increase from 2020.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $10.2M, a 65.9% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$201K +$139K +40.9% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q1 2022 -$339K -$8.31M -104% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q1 2021 $7.97M +$7.4M +1298% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2020 $570K +$637K 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q1 2019 -$67K +$51.2K +43.3% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q1 2018 -$118K +$60.6M +99.8% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q1 2017 -$60.8M 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q1 2015 $3.5M +$267K +8.27% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015
Q1 2014 $3.23M -$5.25M -61.9% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q1 2013 $8.48M +$8.49M 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014
Q1 2012 -$7.39K* -$5.14M 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q1 2011 $5.13M 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012

NAVIDEA BIOPHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7.14M -$4.97M -41% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2023
2021 $12.1M +$1.9M +18.6% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023
2020 $10.2M +$4.05M +65.9% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 $6.16M +$10.7M 01 Jan 2019 31 Dec 2019 10-K 26 Mar 2021
2018 -$4.55M +$56.4M +92.5% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020
2017 -$61M -$51.9M -567% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019
2016 -$9.14M -$29.9M -144% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018
2015 $20.8M +$17.6M +551% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018
2014 $3.19M -$57.5M -94.7% 01 Jan 2014 31 Dec 2014 8-K 15 Dec 2017
2013 $60.7M +$55.7M +1098% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 $5.07M -$6.01M -54.2% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 $11.1M +$4.73M +74.4% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 $6.35M 01 Jan 2010 31 Dec 2010 10-K/A 21 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.